Growing community of inventors

Hong Kong, China

Ming-Liang He

Average Co-Inventor Count = 3.75

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 7

Ming-Liang HeYi Guan (3 patents)Ming-Liang HeHsiang-Fu Kung (3 patents)Ming-Liang HeBo-Jiang Zheng (2 patents)Ming-Liang HeMarie Chia-Mi Lin (2 patents)Ming-Liang HeYing Peng (2 patents)Ming-Liang HeBojian Zheng (1 patent)Ming-Liang HeJiandong Huang (1 patent)Ming-Liang HeYing Chen (1 patent)Ming-Liang HeFanghang Zhou (1 patent)Ming-Liang HeQianya Wan (1 patent)Ming-Liang HeMing-Liang He (5 patents)Yi GuanYi Guan (12 patents)Hsiang-Fu KungHsiang-Fu Kung (4 patents)Bo-Jiang ZhengBo-Jiang Zheng (3 patents)Marie Chia-Mi LinMarie Chia-Mi Lin (2 patents)Ying PengYing Peng (2 patents)Bojian ZhengBojian Zheng (6 patents)Jiandong HuangJiandong Huang (2 patents)Ying ChenYing Chen (1 patent)Fanghang ZhouFanghang Zhou (1 patent)Qianya WanQianya Wan (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The University of Hongkong (3 from 329 patents)

2. City University of Hong Kong (1 from 793 patents)

3. The University of Hong Knog (1 from 1 patent)


5 patents:

1. 12303515 - PIM1 inhibitors for use in treatment of viral infection and pharmaceutical compositions thereof

2. 7491489 - Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof

3. 7429656 - Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference

4. 7129223 - Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference

5. 7067249 - Inhibition of hepatitis B virus (HBV) replication by RNA interference

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…